Company press releases

Displaying 51 - 65 of 65 results
Released Company Title Industry Topic
22 Apr 2022
17:45 CEST 		VETOQUINOL Vetoquinol : Mise à disposition du Document d’enregistrement universel (DEU) 2021 20103015 Pharmaceuticals General meeting / Board Meeting
13 Apr 2022
17:45 CEST 		VETOQUINOL Vetoquinol: Q1 2022 Sales: €135M 20103015 Pharmaceuticals Sales
13 Apr 2022
17:45 CEST 		VETOQUINOL VETOQUINOL : CHIFFRE D’AFFAIRES 1ER TRIMESTRE 2022 : 135M€ 20103015 Pharmaceuticals Sales
24 Mar 2022
07:30 CET 		VETOQUINOL Vetoquinol: 2021 Annual Results 20103015 Pharmaceuticals Sales
24 Mar 2022
07:30 CET 		VETOQUINOL VETOQUINOL : RÉSULTATS ANNUELS 2021 20103015 Pharmaceuticals Sales
20 Jan 2022
19:45 CET 		VETOQUINOL VETOQUINOL : CROISSANCE À DEUX CHIFFRES EN 2021 20103015 Pharmaceuticals Sales
20 Jan 2022
19:45 CET 		VETOQUINOL Vetoquinol: Double-digit Growth In 2021 20103015 Pharmaceuticals Sales
15 Dec 2021
17:50 CET 		VETOQUINOL Vetoquinol : Calendrier de communication financièrepour l’année 2022 20103015 Pharmaceuticals Legal
15 Dec 2021
17:50 CET 		VETOQUINOL Vetoquinol: 2022 Calendar of Financial Communication 20103015 Pharmaceuticals Legal
14 Oct 2021
18:00 CEST 		VETOQUINOL Vetoquinol : Chiffre d’affaires du troisième trimestre : 132M€ 20103015 Pharmaceuticals Sales
14 Oct 2021
18:00 CEST 		VETOQUINOL Vetoquinol: Third Quarter Revenues: €132 Million 20103015 Pharmaceuticals Sales
29 Jul 2021
18:00 CEST 		VETOQUINOL Vetoquinol: 2021 First Half Results 20103015 Pharmaceuticals Income
29 Jul 2021
18:00 CEST 		VETOQUINOL VETOQUINOL : RÉSULTATS SEMESTRIELS 2021 20103015 Pharmaceuticals Income
28 Apr 2021
18:00 CEST 		VETOQUINOL Vetoquinol: Availability of the 2020 Universal Registration Document 20103015 Pharmaceuticals General meeting / Board Meeting
28 Apr 2021
18:00 CEST 		VETOQUINOL Vetoquinol : Mise à disposition du Document d’enregistrement universel (URD) 2020 20103015 Pharmaceuticals General meeting / Board Meeting